Biosimilarity and Interchangeability: Principles and Evidence: A Systematic Review.
Author | |
---|---|
Abstract | :
The efficacy, safety and immunogenicity risk of switching between an originator biologic and a biosimilar or from one biosimilar to another are of potential concern. |
Year of Publication | :
2018
|
Journal | :
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
|
Date Published | :
2018
|
ISSN Number | :
1173-8804
|
URL | :
https://dx.doi.org/10.1007/s40259-017-0256-z
|
DOI | :
10.1007/s40259-017-0256-z
|
Short Title | :
BioDrugs
|
Download citation |